Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Christopher Jones.
Newcastle Authors
Title
Year
Full text
Dr Daniel Williamson
Dr Christopher Jones
Professor Steven Clifford
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group
2018
Dr Sally Hall
Professor Alastair Greystoke
Dr Christopher Jones
Dr Jane Margetts
Crizotinib in clinical practice: the North East of England's experience
2016
James Murray
Huw Thomas
Philip Berry
Suzanne Kyle
Dr Miranda Patterson
et al.
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules
2014
Dr James Hayden
Dr Christopher Jones
Professor Steven Clifford
Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis
2012
Dr Christopher Jones
Dr Andrew Hughes
Prophylactic cranial irradiation (PCI) in extensive stage small cell lung cancer (ED-SCLC): a retrospective review of practice at the Northern Centre for Cancer Treatment
2009
Dr Christopher Jones
Professor Ruth Plummer
PARP inhibitors and cancer therapy - early results and potential applications
2008
Professor Ruth Plummer
Dr Christopher Jones
Professor Nicola Curtin
Professor Alan Boddy
Professor Herbie Newell
et al.
Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors
2008
Dr Robert Thomas
Dr Christopher Jones
Applications of infrared thermography in medicine
2005
Professor Ruth Plummer
Dr Christopher Jones
Lynsey Robson
Professor Alan Calvert
First in human phase I trial of the PARP inhibitor AG-014699 with temozolomide (TMZ) in patients (pts) with advanced solid tumors
2005
Professor Ruth Plummer
Dr Christopher Jones
Professor Alan Boddy
Professor Alan Calvert
Professor Herbie Newell
et al.
Temozolomide pharmacodynamics in patients with metastatic melanoma: DNA damage and activity of repair enzymes
O
6
-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1
2005
Dr Christopher Jones
Dr Niamh Leonard
Pamela Chapman
Professor Sir John Burn
Identification of the familial cylindromatosis tumour-suppressor gene
2000